Mrittika Sengupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mrittika Sengupta has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Manu Smriti Singh
Center for Life Sciences Mahindra University Hyderabad India
1 shared publication Smriti Gaur
Department of Biotechnology, Bennett University, Greater Noida, Uttar Pradesh, India
1 shared publicationSuraj Kumar Modi
Department of Biotechnology, Bennett University, Greater Noida, Uttar Pradesh, India
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 21 April 2023
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 14
Mechanistic insights into nanoparticle surface-bacterial membrane interactions in overcoming antibiotic resistance
Antimicrobial Resistance (AMR) raises a serious concern as it contributes to the global mortality by 5 million deaths per year. The overall impact pertaining to significant membrane changes, through broad spectrum drugs have rendered the bacteria resistant over the years. The economic expenditure due to increasing drug resistance poses a global burden on healthcare community and must be dealt with immediate effect. Nanoparticles (NP) have demonstrated inherent therapeutic potential or can serve as nanocarriers of antibiotics against multidrug resistant (MDR) pathogens. These carriers can mask the antibiotics and help evade the resistance mechanism of the bacteria. The targeted delivery can be fine-tuned through surface functionalization of Nanocarriers using aptamers, antibodies etc. This review covers various molecular mechanisms acquired by resistant bacteria towards membrane modification. Mechanistic insight on ‘NP surface-bacterial membrane’ interactions are crucial in deciding the role of NP as therapeutic. Finally, we highlight the potential accessible membrane targets for designing smart surface-functionalized nanocarriers which can act as bacteria-targeted robots over the existing clinically available antibiotics. As the bacterial strains around us continue to evolve into resistant versions, nanomedicine can offer promising and alternative tools in overcoming AMR.
- 21 April 2023
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 14
Top Cited PapersOpen AccessMechanistic insights into nanoparticle surface-bacterial membrane interactions in overcoming antibiotic resistance
Antimicrobial Resistance (AMR) raises a serious concern as it contributes to the global mortality by 5 million deaths per year. The overall impact pertaining to significant membrane changes, through broad spectrum drugs have rendered the bacteria resistant over the years. The economic expenditure due to increasing drug resistance poses a global burden on healthcare community and must be dealt with immediate effect. Nanoparticles (NP) have demonstrated inherent therapeutic potential or can serve as nanocarriers of antibiotics against multidrug resistant (MDR) pathogens. These carriers can mask the antibiotics and help evade the resistance mechanism of the bacteria. The targeted delivery can be fine-tuned through surface functionalization of Nanocarriers using aptamers, antibodies etc. This review covers various molecular mechanisms acquired by resistant bacteria towards membrane modification. Mechanistic insight on ‘NP surface-bacterial membrane’ interactions are crucial in deciding the role of NP as therapeutic. Finally, we highlight the potential accessible membrane targets for designing smart surface-functionalized nanocarriers which can act as bacteria-targeted robots over the existing clinically available antibiotics. As the bacterial strains around us continue to evolve into resistant versions, nanomedicine can offer promising and alternative tools in overcoming AMR.